1. Signaling Pathways
  2. Protein Tyrosine Kinase/RTK
  3. Bcr-Abl
  4. Bcr-Abl Inhibitors

Bcr-Abl Inhibitors

Abl

Bcr-Abl

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.

Bcr-Abl Inhibitors
Product Name Abl Bcr-Abl Purity
Dasatinib  
Bcr-Abl, IC50: 1.0 nM
99.85%
Nocodazole
Abl, Kd: 91 nM
ABL(E255K), Kd: 120 nM
ABL(T315I), Kd: 170 nM
  99.59%
FGFRs-IN-1
Abl, IC50: 26 nM
 
Naporafenib
Abl1, IC50: 4.9 μM
  99.90%
Dasatinib hydrochloride  
Bcr-Abl, IC50: 1.0 nM
99.67%
AT9283
ABL(T315I), IC50: 4 nM
  99.67%
KW-2449
Abl, IC50: 4 nM
ABL-T315I, IC50: 14 nM
  99.91%
Ponatinib hydrochloride
Abl, IC50: 0.37 nM
  99.76%
GLPG3312
Abl1, IC50: 325 nM
  98.57%
GNF-2  
Bcr-Abl
99.82%
PD173952
Abl, IC50: 1.7 nM
  99.44%
GMB-475  
Bcr-Abl
98.69%
Vodobatinib  
BCR-ABL1, IC50: 7 nM
99.85%
Dasatinib monohydrate  
Bcr-Abl, IC50: 1.0 nM
98.48%
PD180970  
Bcr-Abl, IC50: 5 nM (p210Bcr-Abl kinase)
99.27%
Flumatinib mesylate
c-Abl, IC50: 1.2 nM
  99.80%
PDGFRα kinase inhibitor 2
Abl1, IC50: 6.95 μM
  98.95%
S116836  
Bcr-AblWT
Bcr-AblT315I
99.60%
GZD856 formic  
Bcr-Abl, IC50: 19.9 nM
Bcr-AblT315I, IC50: 15.4 nM
BCR-ABL1-IN-1
Abl1, IC50: 8.7 nM
  99.82%
GZD856  
Bcr-AblT315I, IC50: 15.4 nM
Bcr-Abl, IC50: 19.9 nM
BCR-ABL-IN-3  
Ba/F3Bcr-AblT3151, IC50: ≤100 nM
CHMFL-ABL-121
ABL wt, IC50: 2 nM
ABL-T315I, IC50: 0.2 nM
 
AT9283 lactic acid
ABL(T315I), : 4 nM
 
AP 24149
Abl, IC50: 3.6 nM
 
cSRC/BCR-ABL-IN-1  
Bcr-Abl, IC50: 56.2 nM
ML786 dihydrochloride
Abl1, IC50: <0.5 nM
 
PP487
Abl, IC50: 0.021 μM
 
CHMFL-ABL-053
Abl, IC50: 70 nM
 
Tyrosine kinase-IN-8
Abl1, CC50: 0.8 μM
 
c-ABL-IN-6
c-Abl, IC50: 16.6 nM
 
IHMT-TRK-284
Abl1, IC50: 83.6 nM
 
SNIPER(ABL)-039
Abl, IC50: 0.54 nM
Abl, DC50: 10 nM
 
CHMFL-48  
WT BCR-ABL, IC50: 1 nM
Bcr-AblT315I, IC50: 0.8 nM
ON044580  
WT BCR-ABL
T315I-BCR-ABL